1. Medical Research Council Working Party on Mild Hypertension. MRC trial of treatment of mild hypertension: principal results. Br Med J 1980; 291: 97–104 2. Report by the management committee. The Australian therapeutic trial in mild hypertension. Lancet 1980; i: 1261–1267 3. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results of patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970; 213: 1143–1151 4. US Public Health Service Hospitals Cooperative Study Group. Treatment of mild hypertension. Results of a ten-year intervention trial. Circ Res 1977; 40 (suppl I): I98–I105 5. Helgeland A. Treatment of mild hypertension: a five-year controlled drug trial. The Oslo study. Am J Med 1980; 69: 725–732 6. Multiple Risk Factor Intervention Trial Research Group. Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial. Am J Cardiol 1985; 55: 1–15 7. Miettinen TA. Multifactorial primary prevention of cardiovascular diseases in middle-aged men. Risk factor changes, incidence, and mortality. Journal of the American Medical Association 1985; 254: 2097–2102 8. Amery A, Birkenhager W, Brixko P et al. Mortality and morbidity results from European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1985; i: 1349–1354 9. Hypertension Detection and Follow-up Program Cooperative Group. Five year findings of the hypertension detection and follow-up program, I. Reduction in mortality in persons with high blood pressure, including mild hypertension. JAMA 1979; 242: 2562–2571 10. Freis ED. Rationale against the drug treatment of marginal diastolic systemic hypertension. Am J Cardiol 1990; 66: 368–371 11. Alderman MH. Which antihypertensive drugs first – and why! JAMA 1992; 267: 2786–2787 12. Rouse IL, Beilin LJ, Mahoney DP et al. Vegetarian diet and blood pressure. Lancet 1983; ii: 742–743 13. Silagy CA, Neil HA. A meta-analysis of the effect of garlic on blood pressure. J Hypertens 1994; 12(4): 463–468 14. Jansson B. Dietary, total body, and intracellular potassium-to-sodium ratios and their influence on cancer. Cancer Detect Prevent 1991; 14: 563–565 15. Khaw KT, Barrett-Connor E. Dietary potassium and stroke-associated mortality. N Engl J Med 1987; 316: 235–240 16. Skrabal F, Aubock J, Hortnagl H. Low sodium/high potassium diet for prevention of hypertension. Probable mechanisms of action. Lancet 1981; ii: 895–900 17. Iimura O et al. Studies on the hypotensive effect of high potassium intake in patients with essential hypertension. Clin Sci 1981; 61 (suppl 7): 77s–80s 18. Langford HG. Dietary potassium and hypertension: epidemiological data. Ann Intern Med 1990; 98: 770–772 19. MacGregor SA, Smith SJ, Markand ND et al. Moderate potassium supplementation in essential hypertension. Lancet 1982; ii: 567–570 20. Kaplan NM. Potassium supplementation in hypertensive patients with diuretic-induced hypokalemia. N Engl J Med 1985; 312: 746–749 21. Matlou SM, Isles CG, Higgs A et al. Potassium supplementation in blacks with mild to moderate essential hypertension. J Hypertension 1986; 4: 61–64 22. Obel AO. Placebo controlled trial of potassium supplements in black patients with mild essential hypertension. J Cardiovasc Pharmacol 1989; 14: 294–296 23. Patki PS, Singh J, Gokhale SV et al. Efficacy of potassium and magnesium in essential hypertension: a double-blind, placebo-controlled, crossover study. Br J Med 1990; 301: 521–523 24. Fotherby MD, Potter JF. Potassium supplementation reduces clinic and ambulatory blood pressure in elderly hypertensive patients. J Hypertension 1992; 10: 1403–1408 25. Thijs L, Amery A, Birkenhager W et al. Age-related effects of placebo and active treatment in patients beyond the age of 60 years. The need for a proper control group. J Hypertension 1990; 8: 997–1002 26. Motoyama T, Sano H, Fukuzaki H. Oral magnesium supplementation in patients with essential hypertension. Hypertension 1989; 13: 227–232 27. Whelton PK, Klag MJ. Magnesium and blood pressure: review of the epidemiologic and clinical trial experience. Am J Cardiol 1989; 63: 26G–30G 28. Joffres MR, Reed DM, Yano K. Relatinship of magnesium intake and other dietary factors to blood pressure. The Honolulu Heart Study. Am J Clin Nutr 1987; 45: 469–475 29. Lindberg JS, Zobitz MM, Poindexter JR et al. Magnesium bioavailability from magnesium citrate and magnesium oxide. J Am Coll Nutr 1990; 9: 48–55 30. Bohmer T, Roseth A, Holm H et al. Bioavailability of oral magnesium supplementation in female students evaluated from elimination of magnesium in 24-hour urine. Magnesium Trace Elem 1990; 9: 272–278 31. Kaplan NM. Non-drug treatment of hypertension. Ann Intern Med 1985; 102: 359–373 32. Anderson DE, Bagrov AY, Austin JL. Inhibited breathing decreases renal sodium excretion. Psychosomatic Med 1995; 57: 373–380 33. Simon JA. Vitamin C and cardiovascular disease: a review. J Am Coll Nutr 1992; 11: 107–125 34. Pierkle JL, Schwartz J, Landis JR, Harlan WR. The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. Am J Epid 1985; 121: 246–258 35. Aybak M, Sermet A, Ayyildiz MO et al. Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension. Arzneim Forsch 1995; 45: 1271–1273 36. Cappuccio FP, Elliott P, Allender PS et al. Epidemiologic association between dietary calcium intake and blood pressure. A meta-analysis of published data. Am J Epidemiol 1995; 142: 935–945 37. Meese RB, Gonzales DG, Casparian JM et al. The inconsistent effects of calcium supplements upon blood pressure in primary hypertension. Am J Med Sci 1987; 294: 219–224 38. Sowers JR, Zemel MB, Standley PR et al. Calcium and hypertension. J Lab Clin Med 1989; 114: 338–348 39. Takagi Y, Fukase M, Takata S et al. Calcium treatment of essential hypertension in elderly patients evaluated by 24 H monitoring. Am J Hypertens 1991; 4: 836–839 40. Digiesi V et al. Mechanism of action of coenzyme Q 10 in essential hypertension. Curr Ther Res 1992; 51: 668–672 41. Langsjoen P, Langsjoen P, Willis P et al. Treatment of essential hypertension with coenzyme Q10. Mol Aspects Med 1994; 15(suppl.): S265–272 42. Digiesi V et al. Coenzyme Q10 in essential hypertension. Mol Aspects Med 1994; 15(suppl.): S257–263 43. Schmidt EB, Dyerberg J. Omega-3 fatty acids. Current status in cardiovascular medicine. Drugs 1994; 47: 405–424 44. Appel LJ, Miller ER 3d, Seidler AJ et al. Does supplementation of diet with “fish oil” reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 1993; 153: 1429–1438 45. Singer P. Alpha-linolenic acid vs. long-chain fatty acids in hypertension and hyperlipidemia. Nutr 1992; 8: 133–135 46. Berry EM, Hirsch J. Does dietary linolenic acid influence blood pressure. Am J Clin Nutr 1986; 44: 336–340 47. Petkov V. Plants with hypotensive, antiatheromatous and coronarodilating action. Am J Chin Med 1979; 7: 197–236 48. Ammon HPT, Handel M. Crataegus, toxicology and pharmacology. Part I: Toxicity. Planta Med 1981; 43: 105–120; Part II: Pharmacodynamics. Planta Med 1981; 43: 209–239; Part III: Pharmacodynamics and pharmacokinetics. Planta Med 1981; 43: 313–322 49. Steiner M, Khan AH, Holbert D, Lin RI. A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extracts and placebo administration on blood lipids. Am J Clin Nutr 1996; 64: 866–870 50. Petkov V. Plants with hypotensive, antiatheromatous and coronarodilatating action. Am J Chin Med 1979; 7: 197–236